1. Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
2. Hematology, Department of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy;
3. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy;
4. Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy;
5. Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
6. Hematology Unit, Department of Onco-Hematology, Hospital of Cosenza, Cosenza, Italy;
7. Department of Hematology Oncology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy;
8. Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi” Department of Experimental and Clinical Medical Sciences (DISM), Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy;
9. Cancer Sciences Unit, Southampton Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom;
10. Division of Hematology, University of Siena, Siena, Italy;
11. Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy;
12. Hematology Unit, Hospital of Reggio Calabria, Reggio Calabria, Italy;
13. Department of Hematology, Spedali Civili, Brescia, Italy;
14. Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza and University of Turin, Turin, Italy;
15. Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy;
16. Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy;
17. Department of Clinical Sciences and Community Health, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy;
18. Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy;
19. Section of Hematology, Department of Medicine, University of Verona, Verona, Italy;
20. Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;
21. Department of Hematology, Tor Vergata University, Rome, Italy;
22. Hematology and Cell Therapy Unit, Ospedale Mauriziano and University of Turin, Turin, Italy; and
23. Institute of Hematology ’L. e A. Seràgnoli’, University of Bologna, Bologna, Italy